Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Depreciation & Amortization (CF) (2021 - 2025)

Biote (BTMD) has 5 years of Depreciation & Amortization (CF) data on record, last reported at $952000.0 in Q3 2025.

  • For Q3 2025, Depreciation & Amortization (CF) rose 17.53% year-over-year to $952000.0; the TTM value through Sep 2025 reached $3.9 million, down 2.26%, while the annual FY2024 figure was $3.6 million, 19.37% up from the prior year.
  • Depreciation & Amortization (CF) reached $952000.0 in Q3 2025 per BTMD's latest filing, up from $910000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.5 million in Q4 2023 and bottomed at $180000.0 in Q2 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $689500.0, with a median of $571000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): surged 212.22% in 2022, then decreased 28.28% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $413000.0 in 2021, then skyrocketed by 34.38% to $555000.0 in 2022, then soared by 172.07% to $1.5 million in 2023, then fell by 24.64% to $1.1 million in 2024, then fell by 16.34% to $952000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $952000.0 in Q3 2025, $910000.0 in Q2 2025, and $857000.0 in Q1 2025.